Advertisement

The Scientist

» monoclonal antibodies

Most Recent

image: In Situ Antibodies

In Situ Antibodies

By | February 2, 2016

Compared with systemic injections, localized antibody therapies may be more effective for some indications.

2 Comments

image: Antibody Alternatives

Antibody Alternatives

By and | February 1, 2016

Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

2 Comments

image: Exercises for Your Abs

Exercises for Your Abs

By | February 1, 2016

Companies make the antibodies, but it’s up to you to make sure they work in your experiments.

1 Comment

image: Building Better Reagents

Building Better Reagents

By and | February 1, 2016

Facing problems of inconsistent, time-consuming, and costly antibody production, some researchers are turning to alternatives to target specific proteins of interest, in the lab and in the clinic.

0 Comments

Some antibodies designed to eliminate the plaques prominent in Alzheimer’s disease can aggravate neuronal hyperactivity in mice.

1 Comment

image: Two-Faced Proteins May Tackle HIV Reservoirs

Two-Faced Proteins May Tackle HIV Reservoirs

By | October 21, 2015

Researchers design antibody-like proteins to awaken and destroy HIV holdouts.

0 Comments

image: Novartis Buys Rights to GSK MS Drug for $1 Billion

Novartis Buys Rights to GSK MS Drug for $1 Billion

By | August 24, 2015

The multiple sclerosis treatment has yet to be tested in Phase 3 clinical trials.

0 Comments

image: Moving MERS Therapies Forward

Moving MERS Therapies Forward

By | July 28, 2015

Scientists wonder whether they can obtain the resources to test experimental vaccines and treatments in humans.

3 Comments

image: MERS Research Outpaced by Outbreaks

MERS Research Outpaced by Outbreaks

By | June 18, 2015

Questions about the transmission and pathogenesis of Middle East respiratory syndrome remain as the coronavirus spreads.

1 Comment

image: Funds To Speed Ebola Drug Development

Funds To Speed Ebola Drug Development

By | September 4, 2014

A $42 million US government contract awarded to an experimental Ebola medicine maker aims to accelerate the process of meeting demand for the therapeutic.

0 Comments

Advertisement
EMD Millipore
EMD Millipore

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Turning Tumor Cells Against Cancer
  3. Brazil’s Pre-Zika Microcephaly Cases
    The Nutshell Brazil’s Pre-Zika Microcephaly Cases

    A review of four years’ worth of medical records finds far greater numbers of microcephaly cases from before the ongoing Zika virus epidemic than had been officially reported.

  4. Aging Shrinks Chromosomes
Advertisement
Advertisement
Life Technologies